NCT05607472

Brief Summary

In recent years, dengue has become endemic on La Réunion island, which has led to subsequent increase of secondary dengue infections, higher severity and higher mortality of the cases referred to the hospital. This project will investigate the factors associated with the hospitalization for dengue and the factors associated with dengue severity in a hospital-based cohort study conducted over two dengue seasons, as well as the long-term outcomes over aN18-month follow-up.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
258

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 30, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

3 years

First QC Date

January 6, 2022

Last Update Submit

August 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The relative risk for hospitalization with dengue of any risk factors measured at inclusion )

    The incidence rate ratio (relative risk) for hospitalization with dengue of any risk factors measured at inclusion (first consultation) as identified from a multivariate Poisson regression model for dichotomous outcome.

    18 months

Study Arms (1)

All patient with Dengue prognostic purpose

OTHER

blood samples for bio collection clinical exam : Fitzpatrick phototype classification , Charlson comorbidity classification questionaries : SHERE and EHAD (emotional evaluation), SF-12, EQ-5D-5L, MFIS-5 (Fatigue evaluation)

Other: blood samplingOther: questionnary of health estate during 18 month

Interventions

blood samples for bio collection

All patient with Dengue prognostic purpose

clinical exam Charlson comorbidity classification questionaries : SHERE and EHAD (emotional evaluation), SF-12, EQ-5D-5L, MFIS-5 (Fatigue evaluation) during 18 months

All patient with Dengue prognostic purpose

Eligibility Criteria

Age8 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (including pregnant women) or children (\> 8 kg)
  • Admitted to the Emergency Department, in the hospital wards, or in outpatient clinics from the two teaching hospitals of Réunion island
  • with a definite or probable diagnosis of dengue, as defined by a positive PCR (plasma or urine), NS1 antigen within the first five days of onset of symptoms; or 2 serologies indicating a recent primary or a secondary infection (positive IgM twice or IgG seroconversion x 4 at a minimum of 10 days apart)
  • affiliated to a social insurance

You may not qualify if:

  • refusal of participation as expressed by the patient or its entourage (if the patient is physically unable to give his opinion)
  • absence of social insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Patrick GERARDIN

Saint-Pierre, 97410, France

Location

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Manuella POTHIN

    CHU La Réunion

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2022

First Posted

November 7, 2022

Study Start

March 30, 2022

Primary Completion

March 30, 2025

Study Completion

March 30, 2025

Last Updated

August 21, 2024

Record last verified: 2024-08

Locations